Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suff… (NCT07134686) | Clinical Trial Compass
RecruitingNot Applicable
Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study).
France195 participantsStarted 2026-07-28
Plain-language summary
Asthma affects the lower respiratory tract (bronchi), whereas chronic rhinosinusitis with nasal polyposis (CRSwNP) involves the upper airways. Despite this anatomical distinction, the upper and lower airways form a continuous respiratory tract and share common pathophysiological mechanisms. Consequently, asthma and CRSwNP frequently coexist, and several therapeutic strategies are effective for both conditions.
Given these overlaps, we hypothesize that a multidisciplinary consultation involving both a pulmonologist and an ENT specialist could be more effective than separate consultations for patient care. We also believe that this innovative organization that would benefit the healthcare system.
To test this hypothesis, we are conducting a study whose primary objective is to assess whether joint consultations lead to a reduction in oral corticosteroid need over the year following the initial consultation, by enabling more personalized treatment strategies.
Secondary outcomes will include the frequency of asthma exacerbations, frequency of ENT-related events, respiratory symptoms, quality of life, and healthcare ressources utilization.
We will compare outcomes between two patient groups: one receiving joint consultation from both specialists, and the other managed through standard, separate consultations as per current clinical practice.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female, 18 years of age or older;
* With a diagnosis of asthma;
* With a diagnosis of chronic rhinosinusitis with nasal polyposis;
* Whose asthma and/or chronic rhinosinusitis is/are not controlled according to SNOT-22 and ACQ-6 scores;
* Having used systemic corticosteroids in the previous year to treat symptoms related to one of these conditions at least;
Exclusion Criteria:
* Patient in a period of exclusion from another research protocol at the time of consent signature;
* Subjects covered by articles L1121-5 to 1121-8 of the French Public Health Code (adult patients under guardianship or curatorship, patients deprived of their liberty, pregnant or breast-feeding women);
* Patients who do not read and/or understand French
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study compares a joint ENT and lung specialist consultation to seeing each specialist separately — given that I have both asthma and nasal polyps, do you think a combined consultation model like this could actually change how my care is coordinated right now?
2The trial is measuring whether this approach reduces how much oral corticosteroid I need over a year — since long-term oral corticosteroids carry real risks, is that something you're concerned about in my current treatment plan?
3Because this trial is listed as phase 'not applicable,' it's testing a care delivery model rather than a new drug — does that change the types of risks I should think about before deciding whether to participate?
4The study runs consultations and then follows up at 12 months — how would taking part in this trial affect my existing appointments with you and my other specialists, and would I need to switch to their care team?
5Before considering this trial, should I first make sure my asthma and nasal polyp treatments have been fully optimized with standard care, or is this study designed for people at any stage of managing both conditions?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Effectiveness of joint ENT and pulmonologist consultation on relative change in cumulative annual dose of oral corticosteroids from the year before Baseline to the year between Baseline and 12 months visit.
Timeframe: From the year before Baseline to the 12 months visit.